NCT03781492

Brief Summary

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jan 2006Dec 2026

Study Start

First participant enrolled

January 1, 2006

Completed
13 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 26, 2020

Status Verified

May 1, 2020

Enrollment Period

21 years

First QC Date

December 18, 2018

Last Update Submit

May 21, 2020

Conditions

Stable AnginaCoronary Artery Disease

Outcome Measures

Primary Outcomes (1)

  • Number of participants with reported deaths from any cause

    From date of inclusion until the date of death from any cause, assessed up to 5 year

Secondary Outcomes (3)

  • Number of participants with reported myocardial infarction

    From date of inclusion until the date of first event, assessed up to 5 year

  • Number of participants with reported cerebrovascular insult

    From date of inclusion until the date of first event, assessed up to 5 year

  • Number of participants with reported acute coronary syndrome driven revascularisation

    From date of inclusion until the date of first event, assessed up to 5 year

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is formed by all-comer patients hospitalized in cardiology ward with a diagnosis of stable angina.

You may qualify if:

  • symptom based diagnosis of stable angina

You may not qualify if:

  • acute coronary syndrome on admission
  • ≤ 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

3rd Chair and Department of Cardiology of Silesian Centre for Heart Diseases

Zabrze, Silesian Voivodeship, 41-800, Poland

RECRUITING

MeSH Terms

Conditions

Angina, StableCoronary Artery Disease

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Central Study Contacts

Piotr Desperak, MD

CONTACT

+48514374167desperak.piotr@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 18, 2018

First Posted

December 20, 2018

Study Start

January 1, 2006

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 26, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations

PL(1)